The intersection of substance use with broader public health concerns.
Public Health
Generative Artificial Intelligence-Enabled (GenAI) Digital Mental Health Medical Devices
AGENDA 2025 FDA Perspective: Generative Artificial Intelligence-Enabled (GenAI) Digital Mental Health Medical Devices FDA Perspective: Regulatory Considerations for Digital Mental Health Therapeutics Topic 1: Large Language Models in...
Ethics of artificial intelligence in medicine
This article reviews the main ethical issues that arise from the use of artificial intelligence (AI) technologies in medicine. Issues around trust, responsibility, risks of discrimination, privacy, autonomy, and potential benefits and harms...
Child and youth mental health in the WHO European Region: Status and actions to strengthen quality of care
For the first time WHO Regional Office for Europe brings together all of data available at the Regional level on child and youth mental health. One in seven children and adolescents aged 0–19 years old lives with a mental health condition...
Novel approaches to prevent the recruitment and participation of young people in European drug markets
Objective: This webinar aims to explore innovative and evidence-informed approaches to preventing the recruitment and involvement of young people in drug markets across Europe. Drawing on interventions implemented in various European countries, the session will examine how these strategies can disrupt pathways into drug-related criminality and offer meaningful alternatives for at-risk young people.
European Drugs Summer School 2026
Held in Lisbon, this face-to-face two-week course places special focus on 'A whole-of-society approach to drugs', examining how communities, professionals, policymakers and people who use substances and their families can move from awareness to effective action.
Day 1, 14:00 - 15:30, Plenary 3: Establishing Global-Regional Collaboration in Prevention, Treatment and Recovery Programs
Panel Presented at Indonesia 2025 on the 17th of September 2025 Moderator: Goodman Sibeko Presentations: Ma Veronica Felipe: International Consortium of Universities for Drug Demand Reduction Joanna Travis-Roberts: Global Opportunities for...
The 2025 Global Adderall Shortage: Clinical Impact, Public Health Risks, and Implications for Substance Use Professionals
The 2025 Global Adderall Shortage: Clinical Impact, Public Health Risks, and Implications for Substance Use Professionals Author: Benjamin Zohar, NCACIP – Nationally Certified Advanced Addiction Intervention Professional, Founder of...
Fentanyl in Cocaine: What New York Families Need to Know Right Now
I’m seeing a rise in fentanyl-contaminated cocaine across New York City, Long Island, and the Hudson Valley. I share real cases, warning signs, and harm-reduction strategies families can use—including free 22-panel tests—to prevent fatal overdoses.
